| ... |
SUMMER 2002 Volume 7 / Number 2 |
|
|
Omeprazole Promises Savings on PPI Class By Carl Reed Proton Pump Inhibitors (PPIs) are used to treat stomach problems such as gastric and duodenal ulcers, gastroesophageal reflux and gastrointestinal hypersecretory conditions. While PPIs are not indicated for common "indigestion", some of the class growth in the marketplace may be attributed to this usage. One of the fastest growing class of drugs, PPIs command as much as 8% to 10% of most health plan pharmacy budgets. Omeprazole, the generic form of leading PPI Prilosec® (AstraZeneca), should be available later this year. Strategies for realizing the greatest savings from omeprazole include:
Ongoing member and physician education about the safety and efficacy
of generic drugs also are critical for seizing the savings from omeprazole.
Because different state laws may affect the ability to implement some of
the above strategies or to achieve savings, it is important to know the
requirements of the state(s) in which the majority of your business is conducted. Reed is Director of Pharmacy for Preferred Care, a New York HMO with more than 200,000 lives. He also is a member of the New York State Medicaid Pharmacy & Therapeutics Committee.
|